| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 3e-05 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.14 | 7e-05 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.0002 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |